The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 33 of the 62 sources its claims cite were checked for support.
Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review
Open accessAbstract
Background: Cytochrome P450 oxidoreductase deficiency (PORD) is an ultra-rare autosomal recessive disorder caused by mutations in the POR gene and characterized by highly heterogeneous skeletal, genital, and endocrine manifestations. Owing to this complexity, PORD remains frequently underrecognized in clinical practice, and integrated clinical–genetic syntheses remain limited. Methods: A retrospective analysis was conducted on the clinical data of a PORD patient treated at Shenzhen Children’s Hospital. Relevant literature was retrieved from PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI). Reported cases were analyzed with respect to sex, age, geographic distribution, clinical manifestations, and POR gene variants. Results: The patient from our hospital, a 7-month-old infant, presented with characteristic features including frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities. Genetic testing identified compound heterozygous variants, p.G146fs*111, a novel mutation, and p.R457H. The patient underwent bilateral mandibular distraction osteogenesis and cranial reconstruction, which alleviated airway obstruction, swallowing difficulty, and craniosynostosis. A total of 50 eligible studies were identified, comprising 167 patients (male:female = 77:90). The major clinical findings were skeletal deformities in 124 cases (74.25%), gonadal deformities in 121 (72.46%), hormonal abnormalities or delayed puberty in 127 (76.05%), and adrenal insufficiency or crisis in 108 (64.67%). Additionally, ovarian cysts were observed in 36 female patients (40.00%). Among all patients, the allele frequency of the p.R457H variant was 27.25%, while that of the p.A287P variant was 14.97%. In the 22 Chinese patients, the allele frequency of the p.R457H variant reached 38.64%. Conclusion: We report the clinical features of a PORD patient carrying a novel POR mutation, p.G146fs*111. PORD typically presents with skeletal and genital malformations as well as adrenal insufficiency. Management requires multidisciplinary collaboration, including individualized steroid replacement, regular blood pressure monitoring, and surgical intervention when necessary. The p.R457H variant may represent a hotspot mutation in East Asian populations.
Overview
CoChat Summary
TL;DR
This case report describes a 7-month-old female with P450 oxidoreductase deficiency (PORD) carrying compound heterozygous POR variants, including the novel frameshift p.G146fs*111, and a systematic review of 167 reported PORD patients. The review summarizes common skeletal, gonadal, hormonal, and adrenal manifestations and suggests p.R457H may be a hotspot variant in East Asian populations.
Key findings
- The proband had frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities; genetic testing found compound heterozygous POR variants p.G146fs*111 (novel, maternally inherited) and p.R457H (paternally inherited).
- The patient underwent bilateral mandibular distraction osteogenesis and cranial reconstruction, which alleviated airway obstruction, swallowing difficulty, and craniosynostosis; she was later lost to follow-up.
- In the systematic review of 50 studies and 167 patients (male:female = 77:90), major findings were hormonal abnormalities or delayed puberty in 127 (76.05%), skeletal deformities in 124 (74.25%), gonadal deformities in 121 (72.46%), and adrenal insufficiency or crisis in 108 (64.67%); ovarian cysts occurred in 36 female patients (40.00%).
- The p.A287P allele frequency was 14.97%; the abstract reports p.R457H allele frequency as 27.25% overall, while the Results state p.R457H reached 38.64% and was most common in the Chinese subgroup (38.64%).
Methods
- Retrospective analysis of clinical data from one PORD patient treated at Shenzhen Children’s Hospital, including physical examination, imaging, laboratory testing, treatment, and follow-up.
- Whole-exome sequencing of the proband and parents, with Sanger sequencing validation; variants were prioritized using population databases and in silico tools, and classified per ACMG/AMP 2015 guidelines.
- Systematic review of PubMed, Web of Science, and CNKI from database inception through May 1, 2025, identifying 50 eligible studies and 167 unique PORD patients for analysis of sex, age, region, clinical manifestations, and POR variants.
Limitations
- Stated: the case information came from retrospective medical records, depending on completeness and accuracy; the review relied on published studies rather than direct patient record review.
- Stated: the cohort may not represent the full PORD spectrum because severe cases are more likely to seek care and be reported, while milder or undiagnosed cases may be missed, especially in underserved regions.
- Evident: the report is based on a single case, and the patient was lost to follow-up, limiting longitudinal outcome data; no functional validation of the novel variant is described.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Bilateral elbow joint X-ray of the patient [(A) Anteroposterior view of the left elbow; (B) lateral view of the left elbow; (C) anteroposterior view of the right elbow; (D) lateral view of the right elbow].](https://figures.cochat.ai/paper-figures/4ca3c1abe81e4992a3952792db3a7a83/case-report-integrating-clinical-presentation-and-genetic-analysis-in-p450-figure-4.jpg)



Verification
Claims the paper makes
24 Valid · 5 Not valid · 11 Not checked · 77 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Although earlier studies suggested that the p.R457H variant is associated with more severe skeletal involvement, a study by Dean B et al. reported that patients homozygous for p.R457H did not display more pronounced skeletal defects than those carrying p.R457H in combination with other variants or compared to carriers of p.A287P (17, 34).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Discussion
What the sources say
- Not checked — no full text of the sourcecites [17] Sahakitrungruang, 2009, Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients, J Clin Endocrinol Metab source
- Disputedcites [34] Fan, 2019, Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children, Orphanet J Rare Dis sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says patients with p.R457H tend to have severe skeletal phenotypes, whereas patients with p.A287P are less severely affected—the opposite of the claimed comparison. The Results’ Mutational analysis identifies one p.R457H homozygote but does not report the claimed skeletal-severity comparison with compound heterozygotes. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“According to the ACMG/AMP guidelines, this variant was classified as pathogenic (PVS1 + PM2 + PM3_Supporting) (8).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Results > Pathogenicity of two POR variants
What the sources say
- Partly supportedcites [8] Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med sourceExperimental — accuracy not yet measured
The Pathogenic rules (p. 36) classify a combination of PVS1, one moderate criterion, and one supporting criterion as pathogenic. The guidelines do not identify p.G146fs*111 or establish that it meets PVS1, PM2, and PM3 at supporting strength, so they support the classification rule but not its application to this variant. (LLM, conf=0.85)
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Based on the ACMG/AMP guidelines, it was classified as pathogenic (PS3 + PM2 + PM3_Strong) (8).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Results > Pathogenicity of two POR variants
What the sources say
- Supportedcites [8] Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med source
The guidelines allow PM3 to be upgraded from moderate to strong when the evidence warrants it (Proposed Criteria for Interpretation of Sequence Variants, p. 10). Their pathogenic classification rules require at least two strong criteria (Pathogenic, p. 36), so PS3 plus PM3_Strong meets that threshold. The source provides the classification rules; it does not itself classify p.R457H. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In PORD, impaired function of enzymes such as CYP17A1, CYP19A1, and CYP21A2 disrupts the synthesis of testosterone and dihydrotestosterone, as well as the conversion of androgens to estrogens, resulting in a spectrum of genital anomalies (4, 32, 34, 59).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Discussion
What the sources say
- Supportedcites [4] Bai, 2017, Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review, J Ovarian Res source
The Discussion states that most PORD patients presented with ambiguous genitalia and links this manifestation to impaired testosterone and dihydrotestosterone synthesis and androgen-to-estrogen conversion. It identifies CYP17A1, CYP19A1, and CYP21A2 as POR-dependent enzymes involved in those processes. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [32] Wang, 2018, Clinical characteristics and molecular diagnosis in 2 cases of P450 oxidoreductase deficiency, Chin J Endocrinol Metab doi:10.3760/cma.j.issn.1000-6699.2018.11.006
- Supportedcites [34] Fan, 2019, Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children, Orphanet J Rare Dis source
The Discussion (page not provided) links reduced 17,20-lyase and aromatase activity to disrupted androgen and oestrogen synthesis and disorders of sex development in both sexes. It also identifies altered CYP17A1, CYP19A1 and CYP21A2 activity; the Results report low or normal dihydrotestosterone, undetectable basal testosterone in affected males, and varied external genital findings. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, the reduced activity of hepatic CYP enzymes—including CYP1A2, CYP2C19, and CYP3A4—can significantly alter drug metabolism in PORD patients (7).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Discussion
What the sources say
- Partly supportedcites [7] Hao, 2018, Compound heterozygous variants in POR gene identified by whole-exome sequencing in a Chinese pedigree with cytochrome P450 oxidoreductase deficiency, Pediatr Investig sourceExperimental — accuracy not yet measured
The Discussion says the R457H mutation can inactivate CYP1A2, CYP2C19, and CYP3A4, enzymes important for drug metabolism. It describes altered drug metabolism and medication risks as possibilities for patients with that mutation, rather than establishing a significant effect across PORD patients generally. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
50 more claims · 9 with their cited sources checked
Create a free account to see all 117 claims and to verify the 2 references still open.
- Probably not a substantial claim. 31
- It may state two separate claims as one. 44
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Results > Systematic review results
“The allele frequency of p.A287P was 14.97%, while that of p.R457H reached 38.64%. This latter variant was also the most common in the Chinese subgroup (allele frequency: 38.64%)”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Abstract > Results
“Among all patients, the allele frequency of the p.R457H variant was 27.25%, while that of the p.A287P variant was 14.97%. In the 22 Chinese patients, the allele frequency of the p.R457H variant reached 38.64%.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Discussion
“This high prevalence was later corroborated in a nationwide Japanese study by Yatsuga et al. (68).”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > References
“68. Pandey AV Kempná P Hofer G Mullis PE Flück CE. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Abstract > Results
“proximal radioulnar synostosis”
§ Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review > Results > Laboratory and auxiliary examination
“Radiographs of the elbows demonstrated complete osseous fusion between the distal humerus and the proximal radii”
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 2×
“Based on the ACMG/AMP guidelines, it was classi fi ed as pathogenic (PS3 + PM2 + PM3_Strong) (8).”
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 3×
“It was not until 2004 that Flück CE et al. demonstrated that this novel form of CAH was caused by mutations in the POR gene, which led to impaired activities of multiple CYP enzymes, including CYP21A2, CYP17A1, and CYP19A1 (9).”
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345 · cited 1×
“After birth, shifts in adrenal steroidogenic enzyme expression and a decline in 17 a - hydroxyprogesterone close the backdoor pathway, leading to persistently low androgen levels and arrest of further virilization (32, 62).”
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Meyer, U. A., Zanger, U. M., & Schwab, M. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100502 · Cited by 157 · cited 1×
“Of particular clinical relevance, CYP3A4 is responsible for metabolizing nearly 50% of commonly prescribed medications (65, 66).”
Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148 · cited 7×
“In female patients, fetal CYP17A1 de fi ciency promotes accumulation of adrenal 17 a -hydroxyprogesterone, which is then shunted into the “ backdoor pathway ” to produce elevated levels of the potent androgen dihydrotestosterone (Figure 7) (34).”
InfluentialModulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Pandey, A. V., Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0245 · Cited by 132 · cited 1×
“This high prevalence was later corroborated in a nationwide Japanese study by Yatsuga et al. (68).”
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123 · cited 1×
“In 1985, Peterson RE et al. described a case of congenital adrenal hyperplasia (CAH) exhibiting combined features of 21-hydroxylase de fi ciency (21-OHD) and 17 a -hydroxylase de fi ciency (17-OHD), yet no pathogenic variants were identi fi ed in CYP21A2 or CYP17A1 (3, 56).”
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
Research works printed but not linked: 4
- Wang, 2018, Clinical characteristics and molecular diagnosis in 2 cases of P450 oxidoreductase deficiency, Chin J Endocrinol Metab, 34, 10.3760/cma.j.issn.1000-6699.2018.11.006 · doi:10.3760/cma.j.issn.1000-6699.2018.11.006
- Qi, 2021, Congenital adrenal hyperplasia associated with POR gene mutation: a case report and literature review, Chin Gen Pract, 24, 10.12114/j.issn.1007-9572.2021.00.567 · doi:10.12114/j.issn.1007-9572.2021.00.567
- Zhang, 2022, Cytochrome P450 oxidoreductase deficiency in an infant, Chin J Perinat Med, 25, 10.3760/cma.j.cn113903-20220509-00458 · doi:10.3760/cma.j.cn113903-20220509-00458
- He, 2024, Clinical and genetic characteristics of 22 cases of non - 21 OHD congenital adrenal hyperplasia, Chin J Pract Pediatr, 39, 10.19538/j.ek2024050611 · doi:10.19538/j.ek2024050611
Metadata
- Authors
- Zhang, C., Zhao, Z., Du, Y., Huang, Q., Liu, Y., Fu, G., & Xu, J.
- Affiliations
- Shenzhen Children's Hospital (CN)
- Corresponding author
- Xu, Jianglong
- ORCID
- Huang, Qi
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2026-04-10
- Volume
- 17
- Pages
- 1791297-1791297
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC13105989
- OpenAlex
- W7153120813
- Cited by
- 0
- References
- 64
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Surgery › Craniofacial Disorders and Treatments
- Keywords
- POR gene, compound heterozygosity, craniosynostosis, proximal radioulnar synostosis, adrenal insufficiency, steroid replacement therapy, mandibular distraction osteogenesis, skull reconstruction
- MeSH terms
- Cytochrome P-450 Enzyme System, Female, Genetic Testing, Humans, Infant, Male, Mutation, NADPH-Ferrihemoprotein Reductase, Retrospective Studies, Antley-Bixler Syndrome Phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review. https://app.cochat.ai/papers/10.3389/fendo.2026.1791297
- The paper
- Zhang, C., Zhao, Z., Du, Y., Huang, Q., Liu, Y., Fu, G., & Xu, J. (2026). Case Report: Integrating clinical presentation and genetic analysis in P450 oxidoreductase deficiency: a novel mutation and systematic review. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1791297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.